{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T12:48:37Z","timestamp":1788094117919,"version":"build-2803163510"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03309-y","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T22:14:09Z","timestamp":1769206449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Structurally Modified Cyclodextrins in Topical Nanotechnology: Advancing Barrier-Penetrating Drug Delivery Strategies for Psoriasis Management"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2383-1677","authenticated-orcid":false,"given":"Hrishikesh","family":"Khude","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8144-7645","authenticated-orcid":false,"given":"Pravin","family":"Shende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"3309_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2147\/PTT.S169389","volume":"8","author":"E Yang","year":"2018","unstructured":"Yang E, Beck K, Sanchez I, Koo J, Liao W. The impact of genital psoriasis on quality of life: a systematic review. Psoriasis Targets Ther. 2018;8:41\u20137. https:\/\/doi.org\/10.2147\/PTT.S169389.","journal-title":"Psoriasis Targets Ther"},{"issue":"2","key":"3309_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms26020749","volume":"26","author":"OA Orzan","year":"2025","unstructured":"Orzan OA, Tutunaru CV, Iano\u0219i SL. Understanding the intricate pathophysiology of psoriasis and related skin disorders. Int J Mol Sci. 2025;26(2):1\u201326. https:\/\/doi.org\/10.3390\/ijms26020749.","journal-title":"Int J Mol Sci"},{"key":"3309_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpubh.2025.00713","volume":"13","author":"J Xiong","year":"2025","unstructured":"Xiong J, Xue T, Tong M, Xu L, Bai B. Dynamic trend analysis of global psoriasis burden from 1990 to 2021: a study of gender, age, and regional differences based on GBD 2021 data. Front Public Heal. 2025;13:1\u201313. https:\/\/doi.org\/10.3389\/fpubh.2025.00713.","journal-title":"Front Public Heal"},{"issue":"3","key":"3309_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.065","volume":"76","author":"J Takeshita","year":"2017","unstructured":"Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, et al. Psoriasis and Comorbid Diseases Part I. Epidemiol J Am Acad Dermatol. 2017;76(3):377\u201390. https:\/\/doi.org\/10.1016\/j.jaad.2016.07.065.","journal-title":"Epidemiol J Am Acad Dermatol"},{"issue":"3","key":"3309_CR5","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0190-9622(99)70112-X","volume":"41","author":"SR Rapp","year":"1999","unstructured":"Rapp SR, Feldman SR, Exum ML, Fleischer AB, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41(3):401\u20137. https:\/\/doi.org\/10.1016\/S0190-9622(99)70112-X.","journal-title":"J Am Acad Dermatol"},{"key":"3309_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/PTT.S24009","volume":"2","author":"V Petronic-Rosic","year":"2012","unstructured":"Petronic-Rosic V, Basko-Plluska J. Psoriasis: epidemiology, natural history, and differential diagnosis. Psoriasis Targets Ther. 2012;2:67\u201372. https:\/\/doi.org\/10.2147\/PTT.S24009.","journal-title":"Psoriasis Targets Ther"},{"issue":"18","key":"3309_CR7","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.3889\/oamjms.2019.414","volume":"7","author":"U Wollina","year":"2019","unstructured":"Wollina U, Tirant M, Vojvodic A, Lotti T. Treatment of psoriasis: novel approaches to topical delivery. Open Access Maced J Med Sci. 2019;7(18):3018\u201325. https:\/\/doi.org\/10.3889\/oamjms.2019.414.","journal-title":"Open Access Maced J Med Sci"},{"issue":"22","key":"3309_CR8","doi-asserted-by":"publisher","first-page":"19145","DOI":"10.1021\/acsomega.2c08016","volume":"8","author":"N Raina","year":"2023","unstructured":"Raina N, Rani R, Thakur VK, Gupta M. New insights in topical drug delivery for skin disorders: from a nanotechnological perspective. ACS Omega. 2023;8(22):19145\u201367. https:\/\/doi.org\/10.1021\/acsomega.2c08016.","journal-title":"ACS Omega"},{"issue":"4","key":"3309_CR9","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s13346-021-00909-6","volume":"12","author":"D Ramadon","year":"2022","unstructured":"Ramadon D, McCrudden MTC, Courtenay AJ, Donnelly RF. Enhancement strategies for transdermal drug delivery systems: current trends and applications. Drug Deliv Transl Res. 2022;12(4):758\u201391. https:\/\/doi.org\/10.1007\/s13346-021-00909-6.","journal-title":"Drug Deliv Transl Res"},{"issue":"2","key":"3309_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/10717544.2017.1384520","volume":"24","author":"M Khatoon","year":"2017","unstructured":"Khatoon M, Shah KU, Din FU, Shah SU, Rehman AU, Dilawar N, et al. Proniosomes derived niosomes: recent advancements in drug delivery and targeting. Drug Deliv. 2017;24(2):56\u201369. https:\/\/doi.org\/10.1080\/10717544.2017.1384520.","journal-title":"Drug Deliv"},{"issue":"46","key":"3309_CR11","doi-asserted-by":"publisher","first-page":"29080","DOI":"10.1039\/D1RA06087B","volume":"11","author":"UU Mohd Nordin","year":"2021","unstructured":"Mohd Nordin UU, Ahmad N, Salim N, Mohd Yusof NS. Lipid-based nanoparticles for psoriasis treatment: a review on conventional treatments, recent works, and future prospects. RSC Adv. 2021;11(46):29080\u2013101. https:\/\/doi.org\/10.1039\/D1RA06087B.","journal-title":"RSC Adv"},{"issue":"3","key":"3309_CR12","doi-asserted-by":"publisher","first-page":"460","DOI":"10.5114\/ada.2021.108445","volume":"39","author":"B Zhu","year":"2022","unstructured":"Zhu B, Jing M, Yu Q, Ge X, Yuan F, Shi L. Treatments in psoriasis: from standard pharmacotherapy to nanotechnology therapy. Adv Dermatol Allergol. 2022;39(3):460\u201371. https:\/\/doi.org\/10.5114\/ada.2021.108445.","journal-title":"Adv Dermatol Allergol"},{"issue":"4","key":"3309_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16040449","volume":"16","author":"K Bodn\u00e1r","year":"2024","unstructured":"Bodn\u00e1r K, Feh\u00e9r P, Ujhelyi Z, B\u00e1cskay I, J\u00f3zsa L. Recent approaches for the topical treatment of psoriasis using nanoparticles. Pharmaceutics. 2024;16(4): 564. https:\/\/doi.org\/10.3390\/pharmaceutics16040449.","journal-title":"Pharmaceutics"},{"issue":"8","key":"3309_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms25084547","volume":"25","author":"MA Esteso","year":"2024","unstructured":"Esteso MA, Romero CM. Cyclodextrins: properties and applications. Int J Mol Sci. 2024;25(8):1\u20135. https:\/\/doi.org\/10.3390\/ijms25084547.","journal-title":"Int J Mol Sci"},{"key":"3309_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2023.121500","volume":"324","author":"G Kali","year":"2024","unstructured":"Kali G, Haddadzadegan S, Bernkop-Schn\u00fcrch A. Cyclodextrins and derivatives in drug delivery: new developments, relevant clinical trials, and advanced products. Carbohydr Polym. 2024;324: 121500. https:\/\/doi.org\/10.1016\/j.carbpol.2023.121500.","journal-title":"Carbohydr Polym"},{"key":"3309_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpta.2025.100814","volume":"10","author":"W Zhang","year":"2025","unstructured":"Zhang W, Zhang S, Li X, Tan YQ. Synthesis, characterization and therapeutic advancements in cyclodextrin-based drug delivery systems for oncology: a review. Carbohydrate Polymer Technologies and Applications. 2025;10: 100814. https:\/\/doi.org\/10.1016\/j.carpta.2025.100814.","journal-title":"Carbohydrate Polymer Technologies and Applications"},{"issue":"12","key":"3309_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14122559","volume":"14","author":"T Kovacs","year":"2022","unstructured":"Kovacs T, Nagy P, Panyi G, Szente L, Varga Z, Zakany F. Cyclodextrins: only pharmaceutical excipients or full-fledged drug candidates? Pharmaceutics. 2022;14(12): 2628. https:\/\/doi.org\/10.3390\/pharmaceutics14122559.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3309_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.carbpol.2017.05.086","volume":"173","author":"AP Sherje","year":"2017","unstructured":"Sherje AP, Dravyakar BR, Kadam D, Jadhav M. Cyclodextrin-based nanosponges: a critical review. Carbohydr Polym. 2017;173(1):37\u201349. https:\/\/doi.org\/10.1016\/j.carbpol.2017.05.086.","journal-title":"Carbohydr Polym"},{"issue":"3","key":"3309_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics17030288","volume":"17","author":"OE Nicolaescu","year":"2025","unstructured":"Nicolaescu OE, Belu I, Mocanu AG, Manda VC, R\u0103u G, P\u00eervu AS, et al. Cyclodextrins: Enhancing Drug Delivery, Solubility and Bioavailability for Modern Therapeutics. Pharmaceutics. 2025;17(3):1\u201336. https:\/\/doi.org\/10.3390\/pharmaceutics17030288.","journal-title":"Pharmaceutics"},{"key":"3309_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejpb.2022.07.007","volume":"178","author":"L Ferreira","year":"2022","unstructured":"Ferreira L, Campos J, Veiga F, Cardoso C, Paiva-Santos AC. Cyclodextrin-based delivery systems in parenteral formulations: a critical update review. Eur J Pharm Biopharm. 2022;178:35\u201352. https:\/\/doi.org\/10.1016\/j.ejpb.2022.07.007.","journal-title":"Eur J Pharm Biopharm"},{"issue":"14","key":"3309_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules30143044","volume":"30","author":"I Spiridon","year":"2025","unstructured":"Spiridon I, Anghel N. Cyclodextrins as multifunctional platforms in drug delivery and beyond: structural features, functional applications, and future trends. Molecules. 2025;30(14):1\u201342. https:\/\/doi.org\/10.3390\/molecules30143044.","journal-title":"Molecules"},{"issue":"10","key":"3309_CR22","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1021\/js950534b","volume":"85","author":"ME Brewster","year":"1996","unstructured":"Brewster ME, Loftsson T. Pharmaceutical applications of cyclodextrins . 1 . Drug solubilization and stabilization. J Pharm Sci. 1996;85(10):1017\u201325. https:\/\/doi.org\/10.1021\/js950534b.","journal-title":"J Pharm Sci"},{"issue":"22","key":"3309_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules29225319","volume":"29","author":"AM Musuc","year":"2024","unstructured":"Musuc AM. Cyclodextrins: advances in chemistry, toxicology, and multifaceted applications. Molecules. 2024;29(22):1\u201325. https:\/\/doi.org\/10.3390\/molecules29225319.","journal-title":"Molecules"},{"key":"3309_CR24","unstructured":"Al J et al. Gene alterations NIH public access. BMC Cancer. 2022;23(1):1\u20137. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3624763\/pdf\/nihms412728.pdf. Accessed 27 Oct 2025."},{"issue":"5","key":"3309_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pathogens12050647","volume":"12","author":"S Alboni","year":"2023","unstructured":"Alboni S, Secco V, Papotti B, Vilella A, Adorni MP, Zimetti F, et al. Hydroxypropyl-\u03b2-Cyclodextrin Depletes Membrane Cholesterol and Inhibits SARS-CoV-2 Entry into HEK293T-ACEhi Cells. Pathogens. 2023;12(5):1\u201311. https:\/\/doi.org\/10.3390\/pathogens12050647.","journal-title":"Pathogens"},{"issue":"1\u20132","key":"3309_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0378-5173(97)00387-6","volume":"164","author":"M M\u00e1sson","year":"1998","unstructured":"M\u00e1sson M, Loftsson T, J\u00f3nsd\u00f3ttir S, Fridriksd\u00f3ttir H, Petersen DS. Stabilisation of ionic drugs through complexation with non-ionic and ionic cyclodextrins. Int J Pharm. 1998;164(1\u20132):45\u201355. https:\/\/doi.org\/10.1016\/S0378-5173(97)00387-6.","journal-title":"Int J Pharm"},{"key":"3309_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27659-w","author":"J Park","year":"2022","unstructured":"Park J, Park J, Lee J, Lim C, Lee DW. Size compatibility and concentration dependent supramolecular host\u2013guest interactions at interfaces. Nat Commun. 2022. https:\/\/doi.org\/10.1038\/s41467-021-27659-w.","journal-title":"Nat Commun"},{"issue":"1","key":"3309_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/polysaccharides3010001","volume":"3","author":"BG Poulson","year":"2022","unstructured":"Poulson BG, Alsulami QA, Sharfalddin A, El Agammy EF, Mouffouk F, Emwas AH, et al. Cyclodextrins: Structural, Chemical, and Physical Properties, and Applications. Polysaccharides. 2022;3(1):1\u201331. https:\/\/doi.org\/10.3390\/polysaccharides3010001.","journal-title":"Polysaccharides"},{"key":"3309_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23051161","author":"P Saokham","year":"2018","unstructured":"Saokham P, Muankaew C, Jansook P, Loftsson T. Solubility of cyclodextrins and drug\/cyclodextrin complexes. Molecules. 2018. https:\/\/doi.org\/10.3390\/molecules23051161.","journal-title":"Molecules"},{"key":"3309_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2022.112758","volume":"218","author":"AC Paiva-Santos","year":"2022","unstructured":"Paiva-Santos AC, Ferreira L, Peixoto D, Silva F, Soares MJ, Zeinali M, et al. Cyclodextrins as an encapsulation molecular strategy for volatile organic compounds\u2014 pharmaceutical applications. Colloids Surf B Biointerfaces. 2022;218: 112758. https:\/\/doi.org\/10.1016\/j.colsurfb.2022.112758.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"3","key":"3309_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20030642","volume":"20","author":"SB Carneiro","year":"2019","unstructured":"Carneiro SB, Duarte F\u00cdC, Heimfarth L, Quintans JDSS, Quintans-J\u00fanior LJ, J\u00fanior VFDV, et al. Cyclodextrin-drug inclusion complexes: In vivo and in vitro approaches. Int J Mol Sci. 2019;20(3):1\u201323. https:\/\/doi.org\/10.3390\/ijms20030642.","journal-title":"Int J Mol Sci"},{"key":"3309_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ph16081074","author":"V Aiassa","year":"2023","unstructured":"Aiassa V, Garnero C, Zoppi A, Longhi MR. Cyclodextrins and their derivatives as drug stability modifiers. Pharmaceuticals. 2023. https:\/\/doi.org\/10.3390\/ph16081074.","journal-title":"Pharmaceuticals"},{"issue":"1","key":"3309_CR33","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s10853-019-03983-x","volume":"55","author":"A Celebioglu","year":"2020","unstructured":"Celebioglu A, Uyar T. Electrospinning of cyclodextrins: hydroxypropyl-alpha-cyclodextrin nanofibers. J Mater Sci. 2020;55(1):404\u201320. https:\/\/doi.org\/10.1007\/s10853-019-03983-x.","journal-title":"J Mater Sci"},{"issue":"3","key":"3309_CR34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/BF00708737","volume":"18","author":"P Bak\u00f3","year":"1994","unstructured":"Bak\u00f3 P, Fenichel L, T\u00f6ke L, Szente L, Szejtli J. Methylation of cyclodextrins by phase-transfer catalysis. J Incl Phenom Mol Recognit Chem. 1994;18(3):307\u201314. https:\/\/doi.org\/10.1007\/BF00708737.","journal-title":"J Incl Phenom Mol Recognit Chem"},{"issue":"16","key":"3309_CR35","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1002\/elps.200405839","volume":"25","author":"S Li","year":"2004","unstructured":"Li S, Vigh G. Single-isomer sulfated \u03b1-cyclodextrins for capillary electrophoresis: hexakis(2,3-di-O-methyl-6-O-sulfo)-\u03b1 -cyclodextrin, synthesis, analytical characterization, and initial screening tests. Electrophoresis. 2004;25(16):2657\u201370. https:\/\/doi.org\/10.1002\/elps.200405839.","journal-title":"Electrophoresis"},{"issue":"9","key":"3309_CR36","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1021\/acs.jcim.5b00152","volume":"55","author":"W Khuntawee","year":"2015","unstructured":"Khuntawee W, Wolschann P, Rungrotmongkol T, Wong-Ekkabut J, Hannongbua S. Molecular dynamics simulations of the interaction of beta cyclodextrin with a lipid bilayer. J Chem Inf Model. 2015;55(9):1894\u2013902. https:\/\/doi.org\/10.1021\/acs.jcim.5b00152.","journal-title":"J Chem Inf Model"},{"issue":"2","key":"3309_CR37","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/jctb.2295","volume":"85","author":"C Yanli","year":"2010","unstructured":"Yanli C, Caixia W, Jianwei M, Yongping Y. A facile and practical approach to randomly methylated \u03b2-cyclodextrin. J Chem Technol Biotechnol. 2010;85(2):248\u201351. https:\/\/doi.org\/10.1002\/jctb.2295.","journal-title":"J Chem Technol Biotechnol"},{"issue":"22","key":"3309_CR38","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1016\/j.tet.2016.04.039","volume":"72","author":"DY Ma","year":"2016","unstructured":"Ma DY, Zhang YM, Xu JN. The synthesis and process optimization of sulfobutyl ether \u03b2-cyclodextrin derivatives. Tetrahedron. 2016;72(22):3105\u201312. https:\/\/doi.org\/10.1016\/j.tet.2016.04.039.","journal-title":"Tetrahedron"},{"key":"3309_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65627-4","author":"A Singhal","year":"2020","unstructured":"Singhal A, Krystofiak ES, Jerome WG, Song B. 2-Hydroxypropyl-gamma-cyclodextrin overcomes NPC1 deficiency by enhancing lysosome-ER association and autophagy. Sci Rep. 2020. https:\/\/doi.org\/10.1038\/s41598-020-65627-4.","journal-title":"Sci Rep"},{"issue":"8","key":"3309_CR40","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1080\/00021369.1989.10869626","volume":"53","author":"T Shiraishi","year":"1989","unstructured":"Shiraishi T, Kusano S, Tsumuraya Y, Sakano Y. Synthesis of Maltosyl(\u03b11\u21926)Cyclodextrins through the reverse reaction of thermostable Bacillus Acidopullulyticus pullulanase. Agric Biol Chem. 1989;53(8):2181\u20138. https:\/\/doi.org\/10.1080\/00021369.1989.10869626.","journal-title":"Agric Biol Chem"},{"issue":"7","key":"3309_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13071099","volume":"13","author":"V Aiassa","year":"2021","unstructured":"Aiassa V, Garnero C, Longhi MR, Zoppi A. Cyclodextrin multicomponent complexes: pharmaceutical applications. Pharmaceutics. 2021;13(7): 1099. https:\/\/doi.org\/10.3390\/pharmaceutics13071099.","journal-title":"Pharmaceutics"},{"issue":"7","key":"3309_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071979","volume":"15","author":"X Huang","year":"2023","unstructured":"Huang X, Guo H, Xie Q, Jin W, Zeng R, Hong Z, et al. Preparation and embedding characterization of Hydroxypropyl-\u03b2-cyclodextrin\/menthyl acetate microcapsules with enhanced stability. Pharmaceutics. 2023;15(7): 1979. https:\/\/doi.org\/10.3390\/pharmaceutics15071979.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3309_CR43","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1021\/acsomega.8b02045","volume":"4","author":"ARS Couto","year":"2019","unstructured":"Couto ARS, Ryzhakov A, Larsen KL, Loftsson T. Interaction of native cyclodextrins and their hydroxypropylated derivatives with carbamazepine in aqueous solution. Evaluation of inclusion complexes and aggregates formation. ACS Omega. 2019;4(1):1460\u20139. https:\/\/doi.org\/10.1021\/acsomega.8b02045.","journal-title":"ACS Omega"},{"issue":"10","key":"3309_CR44","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1111\/jdv.14433","volume":"31","author":"G Girolomoni","year":"2017","unstructured":"Girolomoni G, Strohal R, Puig L, Bachelez H, Barker J, Boehncke WH, Prinz JC. The role of IL-23 and the IL-23\/Th17 immune axis in the pathogenesis and treatment of psoriasis. J Eur Acad Dermatol Venereol. 2017;31(10):1616\u201326. https:\/\/doi.org\/10.1111\/jdv.14433.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"3309_CR45","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.3390\/ijms9112278","volume":"9","author":"H Huang","year":"2008","unstructured":"Huang H, Yu H, Li D, Liu Y, Shen F, Zhou J, et al. A novel co-polymer based on hydroxypropyl \u03b1-cyclodextrin conjugated to low molecular weight polyethylenimine as an in vitro gene delivery vector. Int J Mol Sci. 2008;9(11):2278\u201389. https:\/\/doi.org\/10.3390\/ijms9112278.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3309_CR46","doi-asserted-by":"publisher","first-page":"183774","DOI":"10.1016\/j.bbamem.2021.183774","volume":"1864","author":"P Suresh","year":"2021","unstructured":"Suresh P, London E. Using cyclodextrin-induced lipid substitution to study membrane lipid and ordered membrane domain (raft) function in cells. Biochim Biophys Acta Biomembr. 2021;1864(1):183774. https:\/\/doi.org\/10.1016\/j.bbamem.2021.183774.","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"2","key":"3309_CR47","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejps.2006.06.002","volume":"29","author":"K Motoyama","year":"2006","unstructured":"Motoyama K, Arima H, Toyodome H, Irie T, Hirayama F, Uekama K. Effect of 2,6-di-O-methyl-\u03b1-cyclodextrin on hemolysis and morphological change in rabbit\u2019s red blood cells. Eur J Pharm Sci. 2006;29(2):111\u20139. https:\/\/doi.org\/10.1016\/j.ejps.2006.06.002.","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"3309_CR48","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4236\/jeas.2015.53012","volume":"5","author":"T Furuike","year":"2015","unstructured":"Furuike T, Nasu K, Tamura H. Synthesis of sulfated cyclodextrin amphiphiles with liposomal encapsulation properties. J Encapsulation Adsorpt Sci. 2015;5(3):144\u201354. https:\/\/doi.org\/10.4236\/jeas.2015.53012.","journal-title":"J Encapsulation Adsorpt Sci"},{"issue":"16","key":"3309_CR49","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1016\/j.tet.2010.02.015","volume":"66","author":"RA Al-Horani","year":"2010","unstructured":"Al-Horani RA, Desai UR. Chemical sulfation of small molecules \u2013 advances and challenges. Tetrahedron. 2010;66(16):2907\u201318. https:\/\/doi.org\/10.1016\/j.tet.2010.02.015.","journal-title":"Tetrahedron"},{"issue":"21","key":"3309_CR50","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/S0008-6215(03)00356-2","volume":"338","author":"A Dubes","year":"2003","unstructured":"Dubes A, Degobert G, Fessi H, Parrot-Lopez H. Synthesis and characterisation of sulfated amphiphilic \u03b1-, \u03b2- and \u03b3-cyclodextrins: application to the complexation of acyclovir. Carbohydr Res. 2003;338(21):2185\u201393. https:\/\/doi.org\/10.1016\/S0008-6215(03)00356-2.","journal-title":"Carbohydr Res"},{"issue":"11","key":"3309_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/ph15111399","volume":"15","author":"N Ajaz","year":"2022","unstructured":"Ajaz N, Abbas A, Afshan R, Irfan M, Khalid SH, Asghar S, et al. In vitro and in vivo evaluation of Hydroxypropyl-\u03b2-cyclodextrin-grafted-poly(acrylicacid)\/poly(vinyl pyrrolidone) semi-interpenetrating matrices of dexamethasone sodium phosphate. Pharmaceuticals. 2022;15(11): 1399. https:\/\/doi.org\/10.3390\/ph15111399.","journal-title":"Pharmaceuticals"},{"issue":"16","key":"3309_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27165094","volume":"27","author":"T Stolzke","year":"2022","unstructured":"Stolzke T, Krieg F, Peng T, Zhang H, H\u00e4usler O, Brandenbusch C. Hydroxylpropyl-\u03b2-cyclodextrin as potential excipient to prevent stress-induced aggregation in liquid protein formulations. Molecules. 2022;27(16): 5094. https:\/\/doi.org\/10.3390\/molecules27165094.","journal-title":"Molecules"},{"issue":"3","key":"3309_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/gels11030177","volume":"11","author":"H Omidian","year":"2025","unstructured":"Omidian H, Akhzarmehr A, Gill EJ. Cyclodextrin-hydrogel hybrids in advanced drug delivery. Gels. 2025;11(3): 177. https:\/\/doi.org\/10.3390\/gels11030177.","journal-title":"Gels"},{"key":"3309_CR54","doi-asserted-by":"publisher","unstructured":"Chouhan P, Saini TR. Hydroxypropyl- \u03b2 -cyclodextrin: a novel transungual permeation enhancer for development of topical drug delivery system for onychomycosis. J Drug Deliv. 2014;950358:1\u20137. https:\/\/doi.org\/10.1155\/2014\/950358.","DOI":"10.1155\/2014\/950358"},{"key":"3309_CR55","doi-asserted-by":"publisher","DOI":"10.1039\/d5su00590f","author":"LJ Bartlewski","year":"2025","unstructured":"Bartlewski LJ, Conen P, Cai Q, B\u00fcrk M, Armspach D, Meier MAR. A more sustainable two-step synthesis of alkylated \u03b2 cyclodextrin via acetylation and GaBr3-catalyzed reduction. RSC Sustain. 2025. https:\/\/doi.org\/10.1039\/d5su00590f.","journal-title":"RSC Sustain"},{"issue":"18","key":"3309_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26185669","volume":"26","author":"S Bucur","year":"2021","unstructured":"Bucur S, Niculaua M, Ciobanu CI, Lungu NC, Mangalagiu I. A simple synthesis route for selectively methylated \u03b2-cyclodextrin using a copper complex sandwich protecting strategy. Molecules. 2021;26(18): 5669. https:\/\/doi.org\/10.3390\/molecules26185669.","journal-title":"Molecules"},{"key":"3309_CR57","doi-asserted-by":"publisher","first-page":"101238","DOI":"10.1016\/j.jddst.2019.101238","volume":"54","author":"RN Shamma","year":"2019","unstructured":"Shamma RN, Salah Ad-din I, Abdeltawab NF. Dapsone- gel as a novel platform for acne treatment: In vitro evaluation and In vivo performance and histopathological studies in acne infected mice. J Drug Deliv Sci Technol. 2019;54:101238. https:\/\/doi.org\/10.1016\/j.jddst.2019.101238.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"B","key":"3309_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2022.120347","volume":"301","author":"CV Pardeshi","year":"2023","unstructured":"Pardeshi CV, Kothawade RV, Markad AR, Pardeshi SR, Kulkarni AD, Chaudhari PJ, Longhi MR, Dhas N, Naik JB, Surana SJ, Garc\u00eda MC. Sulfobutylether-\u03b2-cyclodextrin: a functional biopolymer for drug delivery applications. Carbohydr Polym. 2023;301(B): 120347. https:\/\/doi.org\/10.1016\/j.carbpol.2022.120347.","journal-title":"Carbohydr Polym"},{"key":"3309_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2024.121985","volume":"333","author":"J Huang","year":"2024","unstructured":"Huang J, Wang X, Huang T, Yang Y, Tu J, Zou J, et al. Application of sodium sulfobutylether-\u03b2-cyclodextrin based on encapsulation. Carbohydr Polym. 2024;333: 121985. https:\/\/doi.org\/10.1016\/j.carbpol.2024.121985.","journal-title":"Carbohydr Polym"},{"issue":"4","key":"3309_CR60","doi-asserted-by":"publisher","first-page":"589","DOI":"10.36468\/pharmaceutical-sciences.549","volume":"81","author":"O Das","year":"2019","unstructured":"Das O, Ghate VM, Lewis SA. Utility of sulfobutyl ether \u03b2-cyclodextrin inclusion complexes in drug delivery: a review. Indian J Pharm Sci. 2019;81(4):589\u2013600. https:\/\/doi.org\/10.36468\/pharmaceutical-sciences.549.","journal-title":"Indian J Pharm Sci"},{"key":"3309_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2023.1138686","volume":"14","author":"Y Ding","year":"2023","unstructured":"Ding Y, Yu B, Zhou S, Ding C, Zhang Z, Xu S, et al. Improvement of solubility and pharmacokinetic profile of hepatoprotector icariin through complexation with HP-\u03b3-cyclodextrin. Front Pharmacol. 2023;14:1\u201312. https:\/\/doi.org\/10.3389\/fphar.2023.1138686.","journal-title":"Front Pharmacol"},{"issue":"5","key":"3309_CR62","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/chir.23300","volume":"33","author":"M Deng","year":"2021","unstructured":"Deng M, Xue M, Liu Y, Zhao M. Preparation of a novel hydroxypropyl-\u03b3-cyclodextrin functionalized monolith for separation of chiral drugs in capillary electrochromatography. Chirality. 2021;33(5):188\u201395. https:\/\/doi.org\/10.1002\/chir.23300.","journal-title":"Chirality"},{"key":"3309_CR63","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ijbiomac.2017.01.144","volume":"98","author":"F Yano","year":"2017","unstructured":"Yano F, Furukawa K, Ueno M, Tokuda H, Okamoto K, Takahashi K, et al. Enhancement of curcumin wound healing ability by complexation with 2-hydroxypropyl-\u03b3-cyclodextrin in sacran hydrogel film. Int J Biol Macromol. 2017;98:268\u201376. https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.01.144.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"3309_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/app15042028","volume":"15","author":"NG Maphuhla","year":"2025","unstructured":"Maphuhla NG, Oyedeji OO. Exploring the efficacy of methylated Gamma-Cyclodextrin (M-\u03b3-CD) in the removal of heavy metals in soil systems. Appl Sci. 2025;15(4): 2028. https:\/\/doi.org\/10.3390\/app15042028.","journal-title":"Appl Sci"},{"issue":"1\u20132","key":"3309_CR65","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ijpharm.2016.10.062","volume":"516","author":"P Saokham","year":"2017","unstructured":"Saokham P, Loftsson T. \u03b3-Cyclodextrin. Int J Pharm. 2017;516(1\u20132):278\u201392. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.10.062.","journal-title":"Int J Pharm"},{"issue":"2","key":"3309_CR66","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ijpharm.2009.05.029","volume":"379","author":"F Mar\u00e7on","year":"2009","unstructured":"Mar\u00e7on F, Mathiron D, Pilard S, Lemaire-Hurtel AS, Dubaele JM, Djedaini-Pilard F. Development and formulation of a 0.2% oral solution of midazolam containing \u03b3-cyclodextrin. Int J Pharm. 2009;379(2):244\u201350. https:\/\/doi.org\/10.1016\/j.ijpharm.2009.05.029.","journal-title":"Int J Pharm"},{"key":"3309_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.carres.2025.109463","author":"Y Okada","year":"2025","unstructured":"Okada Y, Inoue N, Sanagi A, Ichikawa A. Effects of 6-O-\u03b1-maltosyl-\u03b3-cyclodextrin on proliferation and cellular uptake in mouse mastocytoma P-815 cells. Carbohydr Res. 2025. https:\/\/doi.org\/10.1016\/j.carres.2025.109463.","journal-title":"Carbohydr Res"},{"issue":"1","key":"3309_CR68","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou X, Chen Y, Cui L, Shi Y, Guo C. Advances in the pathogenesis of psoriasis: from keratinocyte perspective. Cell Death Dis. 2022;13(1):81. https:\/\/doi.org\/10.1038\/s41419-022-04523-3.","journal-title":"Cell Death Dis"},{"key":"3309_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1081256","volume":"14","author":"P Zhang","year":"2023","unstructured":"Zhang P, Su Y, Li S, Chen H, Wu R, Wu H. The roles of T cells in psoriasis. Front Immunol. 2023;14: 1081256. https:\/\/doi.org\/10.3389\/fimmu.2023.1081256.","journal-title":"Front Immunol"},{"key":"3309_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2022.113012","volume":"221","author":"L Ferreira","year":"2023","unstructured":"Ferreira L, Mascarenhas-Melo F, Raba\u00e7a S, Mathur A, Sharma A, Giram PS, et al. Cyclodextrin-based dermatological formulations: dermopharmaceutical and cosmetic applications. Colloids Surf, B. 2023;221: 113012. https:\/\/doi.org\/10.1016\/j.colsurfb.2022.113012.","journal-title":"Colloids Surf, B"},{"issue":"10","key":"3309_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108932","volume":"24","author":"RG Escobedo-Gonz\u00e1lez","year":"2023","unstructured":"Escobedo-Gonz\u00e1lez RG, Moyers-Montoya ED, Mart\u00ednez-P\u00e9rez CA, Garc\u00eda-Casillas PE, Miranda-Ruvalcaba R, Nicol\u00e1s-V\u00e1zquez MIN. In silico study of novel cyclodextrin inclusion complexes of polycaprolactone and its correlation with skin regeneration. Int J Mol Sci. 2023;24(10): 8932. https:\/\/doi.org\/10.3390\/ijms24108932.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3309_CR72","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.apsb.2019.04.004","volume":"9","author":"Q Zhao","year":"2019","unstructured":"Zhao Q, Ye Z, Su Y, Ouyang D. Predicting complexation performance between cyclodextrins and guest molecules by integrated machine learning and molecular modeling techniques. Acta Pharm Sin B. 2019;9(6):1241\u201352. https:\/\/doi.org\/10.1016\/j.apsb.2019.04.004.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"3309_CR73","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.drudis.2015.11.016","volume":"21","author":"SS Jambhekar","year":"2016","unstructured":"Jambhekar SS, Breen P. Cyclodextrins in pharmaceutical formulations II: solubilization, binding constant, and complexation efficiency. Drug Discov Today. 2016;21(2):363\u20138. https:\/\/doi.org\/10.1016\/j.drudis.2015.11.016.","journal-title":"Drug Discov Today"},{"issue":"5","key":"3309_CR74","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/ddr.21452","volume":"79","author":"S Jacob","year":"2018","unstructured":"Jacob S, Nair AB. Cyclodextrin complexes: perspective from drug delivery and formulation. Drug Dev Res. 2018;79(5):201\u201317. https:\/\/doi.org\/10.1002\/ddr.21452.","journal-title":"Drug Dev Res"},{"issue":"17","key":"3309_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179422","volume":"22","author":"AH Mazurek","year":"2021","unstructured":"Mazurek AH, Szeleszczuk \u0141, Gubica T. Application of molecular dynamics simulations in the analysis of cyclodextrin complexes. Int J Mol Sci. 2021;22(17): 9422. https:\/\/doi.org\/10.3390\/ijms22179422.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3309_CR76","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.ejps.2012.08.004","volume":"47","author":"K Boonyarattanakalin","year":"2012","unstructured":"Boonyarattanakalin K, Wolschann P, Toochinda P, Lawtrakul L. Molecular dynamics simulations of UC781-cyclodextrins inclusion complexes in aqueous solution. Eur J Pharm Sci. 2012;47(4):752\u20138. https:\/\/doi.org\/10.1016\/j.ejps.2012.08.004.","journal-title":"Eur J Pharm Sci"},{"issue":"21","key":"3309_CR77","doi-asserted-by":"publisher","first-page":"5550","DOI":"10.1021\/acs.jpcb.8b02098","volume":"122","author":"T Inoue","year":"2018","unstructured":"Inoue T, Ando Y, Yamakawa N. Predicting the binding mode of 2-hydroxypropyl-\u03b2-cyclodextrin (HP\u03b2CD) to cholesterol by means of the MD simulation and the 3D-RISM-KH theory. J Phys Chem B. 2018;122(21):5550\u20139. https:\/\/doi.org\/10.1021\/acs.jpcb.8b02098.","journal-title":"J Phys Chem B"},{"issue":"2","key":"3309_CR78","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.bmc.2008.11.040","volume":"17","author":"A P\u00e9rez-Garrido","year":"2009","unstructured":"P\u00e9rez-Garrido A, Helguera AM, Guill\u00e9n AA, Cordeiro MNDS, Escudero AG. Convenient QSAR model for predicting the complexation of structurally diverse compounds with \u03b2-cyclodextrins. Bioorg Med Chem. 2009;17(2):896\u2013904. https:\/\/doi.org\/10.1016\/j.bmc.2008.11.040.","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"3309_CR79","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s44371-025-00152-9","volume":"2","author":"F Kurul","year":"2025","unstructured":"Kurul F, Doruk B, Topkaya SN. Principles of green chemistry: building a sustainable future. Discov Chem. 2025;2(1):68. https:\/\/doi.org\/10.1007\/s44371-025-00152-9.","journal-title":"Discov Chem"},{"key":"3309_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2025.141326","volume":"1328","author":"BG Fouda-Mbanga","year":"2025","unstructured":"Fouda-Mbanga BG, Tywabi-Ngeva Z, Badawy WM, Ebite C, Onotu OP, Abogidi C, et al. Green cyclodextrins-derivatives for sustainable remediation of pesticides and heavy metals: a review. J Mol Struct. 2025;1328: 141326. https:\/\/doi.org\/10.1016\/j.molstruc.2025.141326.","journal-title":"J Mol Struct"},{"issue":"3","key":"3309_CR81","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2174\/1389557510909030340","volume":"9","author":"V Santagada","year":"2012","unstructured":"Santagada V, Frecentese F, Perissutti E, Fiorino F, Severino B, Caliendo G. Microwave assisted synthesis: a new technology in drug discovery. Mini Rev Med Chem. 2012;9(3):340\u201358. https:\/\/doi.org\/10.2174\/1389557510909030340.","journal-title":"Mini Rev Med Chem"},{"issue":"4","key":"3309_CR82","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1039\/D4RA06886F","volume":"15","author":"S Swami","year":"2025","unstructured":"Swami S, Sharma N, Sharma G, Shrivastava R. Recent advances in microwave-assisted synthesis of triazoles and their derivatives: a green approach toward sustainable development methods. RSC Adv. 2025;15(4):2361\u2013415.","journal-title":"RSC Adv"},{"issue":"47","key":"3309_CR83","doi-asserted-by":"publisher","first-page":"32858","DOI":"10.1039\/D4RA06886F","volume":"13","author":"G Tiwari","year":"2023","unstructured":"Tiwari G, Khanna A, Mishra VK, Sagar R. Recent developments on microwave-assisted organic synthesis of nitrogen- and oxygen-containing preferred heterocyclic scaffolds. RSC Adv. 2023;13(47):32858\u201392. https:\/\/doi.org\/10.1039\/D4RA06886F.","journal-title":"RSC Adv"},{"key":"3309_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2020.117003","volume":"250","author":"J Qu","year":"2020","unstructured":"Qu J, Dong M, Wei S, Meng Q, Hu L, Hu Q, et al. Microwave-assisted one pot synthesis of \u03b2-cyclodextrin modified biochar for concurrent removal of Pb(II) and bisphenol a in water. Carbohydr Polym. 2020;250: 117003. https:\/\/doi.org\/10.1016\/j.carbpol.2020.117003.","journal-title":"Carbohydr Polym"},{"issue":"2","key":"3309_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e06305","volume":"7","author":"CH Lim","year":"2021","unstructured":"Lim CH, Rasti B, Sulistyo J, Hamid MA. Comprehensive study on transglycosylation of CGTase from various sources. Heliyon. 2021;7(2): e06305. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06305.","journal-title":"Heliyon"},{"issue":"3","key":"3309_CR86","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/s0168-1656(03)00126-3","volume":"103","author":"H Leemhuis","year":"2003","unstructured":"Leemhuis H, Kragh KM, Dijkstra BW, Dijkhuizen L. Engineering cyclodextrin glycosyltransferase into a starch hydrolase with a high exo-specificity. J Biotechnol. 2003;103(3):203\u201312. https:\/\/doi.org\/10.1016\/s0168-1656(03)00126-3.","journal-title":"J Biotechnol"},{"issue":"2","key":"3309_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/catal15020120","volume":"15","author":"J Wang","year":"2025","unstructured":"Wang J, Wang B, Zhou J, Dong J, Ni Y, Han R. Engineering of Cyclodextrin Glucosyltransferase from Paenibacillus macerans for Improved Regioselectivity and Product Specificity Toward Hydroxyflavone Glycosylation. Catalysts. 2025;15(2):1\u201313. https:\/\/doi.org\/10.3390\/catal15020120.","journal-title":"Catalysts"},{"issue":"8","key":"3309_CR88","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/j.chempr.2021.05.013","volume":"7","author":"S Yang","year":"2021","unstructured":"Yang S, Larsen D, Pellegrini M, Meier S, Mierke DF, Beeren SR, et al. Dynamic enzymatic synthesis of \u03b3-cyclodextrin using a photoremovable hydrazone template. Chem. 2021;7(8):2190\u2013200. https:\/\/doi.org\/10.1016\/j.chempr.2021.05.013.","journal-title":"Chem"},{"issue":"1","key":"3309_CR89","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11356-021-15187-5","volume":"29","author":"A Rubin Pedrazzo","year":"2022","unstructured":"Rubin Pedrazzo A, Trotta F, Hoti G, Cesano F, Zanetti M. Sustainable mechanochemical synthesis of \u03b2-cyclodextrin polymers by twin screw extrusion. Environ Sci Pollut Res. 2022;29(1):251\u201363. https:\/\/doi.org\/10.1007\/s11356-021-15187-5.","journal-title":"Environ Sci Pollut Res"},{"issue":"17","key":"3309_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/polym17172340","volume":"17","author":"Z Qiang","year":"2025","unstructured":"Qiang Z, Hu J, Jiang B. Mechanochemical synthesis of advanced materials for all-solid-state battery (ASSB) applications: a review. Polymers. 2025;17(17): 2340. https:\/\/doi.org\/10.3390\/polym17172340.","journal-title":"Polymers"},{"issue":"17","key":"3309_CR91","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3390\/polym17172340","volume":"17","author":"AR Pedrazzo","year":"2020","unstructured":"Pedrazzo AR, Caldera F, Zanetti M, Appleton SL, Dhakar NK, Trotta F. Mechanochemical green synthesis of hyper-crosslinked cyclodextrin polymers. Beilstein J Org Chem. 2020;17(17):1554\u201363. https:\/\/doi.org\/10.3390\/polym17172340.","journal-title":"Beilstein J Org Chem"},{"issue":"240","key":"3309_CR92","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jconrel.2015.11.009","volume":"28","author":"KS Soni","year":"2016","unstructured":"Soni KS, Desale SS, Bronich TK. Nanogels: an overview of properties, biomedical applications and obstacles to clinical translation. J Control Release. 2016;28(240):109\u201326. https:\/\/doi.org\/10.1016\/j.jconrel.2015.11.009.","journal-title":"J Control Release"},{"key":"3309_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2025.102645","volume":"61","author":"L Blagojevic","year":"2025","unstructured":"Blagojevic L, Kamaly N. Nanogels: a chemically versatile drug delivery platform. Nano Today. 2025;61: 102645. https:\/\/doi.org\/10.1016\/j.nantod.2025.102645.","journal-title":"Nano Today"},{"issue":"10","key":"3309_CR94","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1016\/j.bioactmat.2021.03.004","volume":"6","author":"D Keskin","year":"2021","unstructured":"Keskin D, Zu G, Forson AM, Tromp L, Sjollema J, van Rijn P. Nanogels: a novel approach in antimicrobial delivery systems and antimicrobial coatings. Bioact Mater. 2021;6(10):3634\u201357. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.03.004.","journal-title":"Bioact Mater"},{"key":"3309_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.rsurfi.2025.100529","volume":"19","author":"S Islam","year":"2025","unstructured":"Islam S, Ahmed MMS, Islam MA, Hossain N, Chowdhury MA. Advances in nanoparticles in targeted drug delivery\u2013a review. Results in Surfaces and Interfaces. 2025;19: 100529. https:\/\/doi.org\/10.1016\/j.rsurfi.2025.100529.","journal-title":"Results in Surfaces and Interfaces"},{"key":"3309_CR96","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.2147\/IJN.S246783","volume":"15","author":"L Wu","year":"2020","unstructured":"Wu L, Liu G, Wang W, Liu R, Liao L, Cheng N, et al. Cyclodextrin-modified CeO2 nanoparticles as a multifunctional nanozyme for combinational therapy of psoriasis. Int J Nanomedicine. 2020;15:2515\u201327. https:\/\/doi.org\/10.2147\/IJN.S246783.","journal-title":"Int J Nanomedicine"},{"issue":"5","key":"3309_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e09394","volume":"8","author":"H Nsairat","year":"2022","unstructured":"Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. Liposomes: structure, composition, types, and clinical applications. Heliyon. 2022;8(5): e09394. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09394.","journal-title":"Heliyon"},{"key":"3309_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.onano.2023.100132","volume":"11","author":"H Nsairat","year":"2023","unstructured":"Nsairat H, Alshaer W, Odeh F, Esawi E, Khater D, Bawab AA, et al. Recent advances in using liposomes for delivery of nucleic acid-based therapeutics. Open Nano. 2023;11: 100132. https:\/\/doi.org\/10.1016\/j.onano.2023.100132.","journal-title":"Open Nano"},{"issue":"34","key":"3309_CR99","doi-asserted-by":"publisher","first-page":"40228","DOI":"10.1021\/acsami.3c07582","volume":"15","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Gong S, Liu L, Shen H, Liu E, Pan L, et al. Cyclodextrin-coordinated liposome-in-gel for transcutaneous Quercetin delivery for psoriasis treatment. ACS Appl Mater Interfaces. 2023;15(34):40228\u201340. https:\/\/doi.org\/10.1021\/acsami.3c07582.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"2","key":"3309_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm10020181","volume":"10","author":"V Alimardani","year":"2021","unstructured":"Alimardani V, Abolmaali SS, Yousefi G, Rahiminezhad Z, Abedi M, Tamaddon A, et al. Microneedle arrays combined with nanomedicine approaches for transdermal delivery of therapeutics. J Clin Med. 2021;10(2):1\u201333. https:\/\/doi.org\/10.3390\/jcm10020181.","journal-title":"J Clin Med"},{"issue":"12","key":"3309_CR101","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.1016\/j.apsb.2024.08.013","volume":"14","author":"C Wu","year":"2024","unstructured":"Wu C, Yu Q, Huang C, Li F, Zhang L, Zhu D. Microneedles as transdermal drug delivery system for enhancing skin disease treatment. Acta Pharm Sin B. 2024;14(12):5161\u201380. https:\/\/doi.org\/10.1016\/j.apsb.2024.08.013.","journal-title":"Acta Pharm Sin B"},{"issue":"12","key":"3309_CR102","doi-asserted-by":"publisher","first-page":"15162","DOI":"10.1021\/acsami.3c00058","volume":"15","author":"H Wang","year":"2023","unstructured":"Wang H, Fu Y, Liu P, Qu F, Du S, Li Y, et al. Supramolecular dissolving microneedle patch loading hydrophobic glucocorticoid for effective psoriasis treatment. ACS Appl Mater Interfaces. 2023;15(12):15162\u201371. https:\/\/doi.org\/10.1021\/acsami.3c00058.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"22","key":"3309_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/polym15224369","volume":"15","author":"M P\u00e9rez-Ferreiro","year":"2023","unstructured":"P\u00e9rez-Ferreiro M, M. Abelairas A, Criado A, G\u00f3mez IJ, Mosquera J. Dendrimers: exploring their wide structural variety and applications. Polymers. 2023;15(22): 4369. https:\/\/doi.org\/10.3390\/polym15224369.","journal-title":"Polymers"},{"key":"3309_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.nwnano.2025.100094","volume":"9","author":"AA Dehkordi","year":"2025","unstructured":"Dehkordi AA, Mollazadeh S, Talaie A, Yazdimamaghani M. Engineering PAMAM dendrimers for optimized drug delivery. Nano Trends. 2025;9: 100094. https:\/\/doi.org\/10.1016\/j.nwnano.2025.100094.","journal-title":"Nano Trends"},{"issue":"11","key":"3309_CR105","doi-asserted-by":"publisher","first-page":"26363","DOI":"10.3390\/ijms161125956","volume":"16","author":"DM Shadrack","year":"2015","unstructured":"Shadrack DM, Mubofu EB, Nyandoro SS. Synthesis of polyamidoamine dendrimer for encapsulating tetramethylscutellarein for potential bioactivity enhancement. Int J Mol Sci. 2015;16(11):26363\u201377. https:\/\/doi.org\/10.3390\/ijms161125956.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"3309_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/polym14122510","volume":"14","author":"S Perumal","year":"2022","unstructured":"Perumal S, Atchudan R, Lee W. A review of polymeric micelles and their applications. Polymers (Basel). 2022;14(12):1\u201319. https:\/\/doi.org\/10.3390\/polym14122510.","journal-title":"Polymers (Basel)"},{"issue":"4","key":"3309_CR107","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1208\/s12249-014-0113-z","volume":"15","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Huang Y, Li S. Polymeric micelles: nanocarriers for cancer-targeted drug delivery. AAPS PharmSciTech. 2014;15(4):862\u201371. https:\/\/doi.org\/10.1208\/s12249-014-0113-z.","journal-title":"AAPS PharmSciTech"},{"key":"3309_CR108","doi-asserted-by":"publisher","first-page":"100118","DOI":"10.1016\/j.ijpx.2022.100118","volume":"4","author":"AP Krawczyk-Santos","year":"2022","unstructured":"Krawczyk-Santos AP, Marreto RN, Concheiro A, Alvarez-Lorenzo C, Taveira SF. Poly(pseudo)rotaxanes formed by mixed micelles and \u03b1-cyclodextrin enhance terbinafine nail permeation to deeper layers. Int J Pharm X. 2022;4:100118. https:\/\/doi.org\/10.1016\/j.ijpx.2022.100118.","journal-title":"Int J Pharm X"},{"key":"3309_CR109","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejpb.2019.08.015","volume":"144","author":"S Chen","year":"2019","unstructured":"Chen S, Hanning S, Falconer J, Locke M, Wen J. Recent advances in non-ionic surfactant vesicles (niosomes): fabrication, characterization, pharmaceutical and cosmetic applications. Eur J Pharm Biopharm. 2019;144:18\u201339. https:\/\/doi.org\/10.1016\/j.ejpb.2019.08.015.","journal-title":"Eur J Pharm Biopharm"},{"key":"3309_CR110","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/198268","author":"B Gidwani","year":"2015","unstructured":"Gidwani B, Vyas A. A comprehensive review on cyclodextrin-based carriers for delivery of chemotherapeutic cytotoxic anticancer drugs. Biomed Res Int. 2015. https:\/\/doi.org\/10.1155\/2015\/198268.","journal-title":"Biomed Res Int"},{"issue":"52","key":"3309_CR111","doi-asserted-by":"publisher","first-page":"29909","DOI":"10.1039\/C8RA05021J","volume":"8","author":"ND Machado","year":"2018","unstructured":"Machado ND, Silva OF, De Rossi RH, Fern\u00e1ndez MA. Cyclodextrin modified niosomes to encapsulate hydrophilic compounds. RSC Adv. 2018;8(52):29909\u201316. https:\/\/doi.org\/10.1039\/C8RA05021J.","journal-title":"RSC Adv"},{"issue":"1","key":"3309_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e23303","volume":"10","author":"A Garg","year":"2024","unstructured":"Garg A, Lai WC, Chopra H, Agrawal R, Singh T, Chaudhary R, et al. Nanosponge: a promising and intriguing strategy in medical and pharmaceutical science. Heliyon. 2024;10(1): e23303. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23303.","journal-title":"Heliyon"},{"issue":"1\u20134","key":"3309_CR113","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/S10847-006-9216-9","volume":"57","author":"S Swaminathan","year":"2007","unstructured":"Swaminathan S, Vavia PR, Trotta F, Torne S. Formulation of betacyclodextrin based nanosponges of itraconazole. J Incl Phenom Macrocycl Chem. 2007;57(1\u20134):89\u201394. https:\/\/doi.org\/10.1007\/S10847-006-9216-9.","journal-title":"J Incl Phenom Macrocycl Chem"},{"key":"3309_CR114","doi-asserted-by":"publisher","first-page":"104840","DOI":"10.1016\/j.jddst.2023.104840","volume":"87","author":"MM Anjum","year":"2023","unstructured":"Anjum MM, Kumar DN, Bhattacharya S, Patel KK, Vijayakumar MR, Agrawal AK, et al. Topical delivery of cyclodextrin crosslinked nanosponge of anacardic acid for treatment of UV-B induced skin photoaging: formulation, characterization and biochemical estimation. J Drug Deliv Sci Technol. 2023;87:104840. https:\/\/doi.org\/10.1016\/j.jddst.2023.104840.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"12","key":"3309_CR115","doi-asserted-by":"publisher","DOI":"10.3390\/biom9120801","volume":"9","author":"SS Braga","year":"2019","unstructured":"Braga SS. Cyclodextrins: emerging medicines of the new millennium. Biomolecules. 2019;9(12): 801. https:\/\/doi.org\/10.3390\/biom9120801.","journal-title":"Biomolecules"},{"issue":"1","key":"3309_CR116","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s44274-024-00090-w","volume":"2","author":"T Urooj","year":"2024","unstructured":"Urooj T, Mishra M, Pandey S. Unlocking environmental solutions: a review of cyclodextrins in pollutant removal. Discov Environ. 2024;2(1):65. https:\/\/doi.org\/10.1007\/s44274-024-00090-w.","journal-title":"Discov Environ"},{"issue":"8","key":"3309_CR117","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.bpj.2019.03.016","volume":"116","author":"A Biswas","year":"2019","unstructured":"Biswas A, Kashyap P, Datta S, Sengupta T, Sinha B. Cholesterol depletion by M\u03b2CD enhances cell membrane tension and its variations-reducing integrity. Biophys J. 2019;116(8):1456\u201368. https:\/\/doi.org\/10.1016\/j.bpj.2019.03.016.","journal-title":"Biophys J"},{"issue":"3","key":"3309_CR118","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ejpb.2003.12.004","volume":"57","author":"G Piel","year":"2004","unstructured":"Piel G, Moutard S, Uhoda E, Pilard F, Pi\u00e9rard GE, Perly B, et al. Skin compatibility of cyclodextrins and their derivatives: a comparative assessment using a corneoxenometry bioassay. Eur J Pharm Biopharm. 2004;57(3):479\u201382. https:\/\/doi.org\/10.1016\/j.ejpb.2003.12.004.","journal-title":"Eur J Pharm Biopharm"},{"key":"3309_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/950358","volume":"2014","author":"P Chouhan","year":"2014","unstructured":"Chouhan P, Saini TR. Hydroxypropyl- \u03b2 -cyclodextrin: a novel transungual permeation enhancer for development of topical drug delivery system for onychomycosis. J Drug Deliv. 2014;2014:1\u20137. https:\/\/doi.org\/10.1155\/2014\/950358.","journal-title":"J Drug Deliv"},{"key":"3309_CR120","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.3762\/bjoc.12.261","volume":"12","author":"L Leclercq","year":"2016","unstructured":"Leclercq L. Interactions between cyclodextrins and cellular components: towards greener medical applications? Beilstein J Org Chem. 2016;12:2644\u201362. https:\/\/doi.org\/10.3762\/bjoc.12.261.","journal-title":"Beilstein J Org Chem"},{"issue":"19","key":"3309_CR121","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910841","volume":"22","author":"A Orsmond","year":"2021","unstructured":"Orsmond A, Bereza-Malcolm L, Lynch T, March L, Xue M. Skin barrier dysregulation in psoriasis. Int J Mol Sci. 2021;22(19): 10841. https:\/\/doi.org\/10.3390\/ijms221910841.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3309_CR122","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000349991","volume":"226","author":"G Senti","year":"2013","unstructured":"Senti G, Iannaccone R, Graf N, Felder M, Tay F, K\u00fcndig T. A randomized, double-blind, placebo-controlled study to test the efficacy of topical 2-hydroxypropyl-\u03b2-cyclodextrin in the prophylaxis of recurrent herpes labialis. Dermatology. 2013;226(3):247\u201352. https:\/\/doi.org\/10.1159\/000349991.","journal-title":"Dermatology"},{"issue":"3","key":"3309_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12030231","volume":"12","author":"E Cutr\u00edn-G\u00f3mez","year":"2020","unstructured":"Cutr\u00edn-G\u00f3mez E, Conde-Penedo A, Anguiano-Igea S, G\u00f3mez-Amoza JL, Otero-Espinar FJ. Optimization of drug permeation from 8% ciclopirox cyclodextrin\/poloxamer-soluble polypseudorotaxane-based nail lacquers. Pharmaceutics. 2020;12(3): 231. https:\/\/doi.org\/10.3390\/pharmaceutics12030231.","journal-title":"Pharmaceutics"},{"key":"3309_CR124","doi-asserted-by":"crossref","unstructured":"Schoeppe F, Franca J, Fandino W, Siqueira A, Gadallah A, et al. Efficacy of topical dexamethasone-cyclodextrin microparticle eye drops compared with ranibizumab in diabetic macular edema: a phase II, multicenter, randomized controlled non-inferiority trial. Princ Pract Clin Res J. 2017;3(1):28\u201335. Available from: https:\/\/journal.ppcr.org\/index.php\/ppcrjournal\/article\/view\/47. Accessed 27 Oct 2025.","DOI":"10.21801\/ppcrj.2017.31.4"},{"key":"3309_CR125","unstructured":"Western University of Health Sciences. Topical absorption of glutathione-cyclodextrin complex in healthy human subjects improves immune response against mycobacterium infection 2022. Study ID: NCT05926245. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05926245. Accessed 28 Oct 2025."},{"key":"3309_CR126","unstructured":"European Medicines Agency. Cyclodextrins used as excipients. 2017;44(EMA\/CHMP\/333892\/2013):1\u201316. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/questions-answers-cyclodextrins-used-excipientsmedicinal-products-human-use_en. Accessed 28 Oct 2025."}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03309-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03309-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03309-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T21:46:52Z","timestamp":1772228812000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03309-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":126,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["3309"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03309-y","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethical approvals were required for this review and no human subjects were involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"This review article does not require consent for publication as no human subjects were involved.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no conflict of interest that could influence this review article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"84"}}